Study on Intervention Value of Pharmaceutical Care Pathway Management on Drug Use Rate in Patients with Acute Coronary Syndrome

Cai Liwen, Zhang Bin, Wang Xinyu

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (9) : 1074-1082.

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (9) : 1074-1082. DOI: 10.16153/j.1002-7777.2023.09.012
Hospital Pharmaceutical Affairs

Study on Intervention Value of Pharmaceutical Care Pathway Management on Drug Use Rate in Patients with Acute Coronary Syndrome

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 37(9): 1074-1082 https://doi.org/10.16153/j.1002-7777.2023.09.012

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉